Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Plunkett Research, Ltd.
$99.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Novartis AG Issues FY 2013 Revenue Guidance In Line With Analysts' Estimates-Conference Call


Wednesday, 23 Jan 2013 01:00pm EST 

Novartis AG announced that for fiscal 2013, it expects Group net sales expected to be in line with 2012. The Company reported revenue of $56.67 billion in fiscal 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $57.2 billion for fiscal 2013. 

Company Quote

79.95
-0.45 -0.56%
11:32am EDT